Response to "Inhibition of p300 and nuclear factor-κB by curcumin and its role in diabetic nephropathy"

Nutrition

Volumn 25, Issue 9, 2009, Pages 975-976

  Khan, Zia A ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CURCUMIN; DIMETHYL SULFOXIDE; HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; LETTER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 67849126812     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.05.009     Document Type: Letter

References (24)

1. Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25 (1976) 1811-1812
2. Srimal R.C., and Dhawan B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25 (1973) 447-452
3. Gaedeke J., Noble N.A., and Border W.A. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66 (2004) 112-120
4. Kuwabara N., Tamada S., Iwai T., Teramoto K., Kaneda N., Yukimura T., et al. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology 67 (2006) 440-446
5. Punithavathi D., Venkatesan N., and Babu M. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131 (2000) 169-172
6. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., and Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94 (1995) 79-83
7. Anand P., Kunnumakkara A.B., Newman R.A., and Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharmacol 4 (2007) 807-818
8. Sun J., Yang D., Li S., Xu Z., Wang X., and Bai C. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats. Eur Respir J 33 (2009) 398-404
9. Ghoneim A.I., Abdel-Naim A.B., Khalifa A.E., and El-Denshary E.S. Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 46 (2002) 273-279
10. Dujic J., Kippenberger S., Ramirez-Bosca A., Diaz-Alperi J., Bereiter-Hahn J., Kaufmann R., et al. Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. Int J Cancer 124 (2009) 1422-1428
11. Pan M.H., Huang T.M., and Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27 (1999) 486-494
12. Li H.L., Liu C., de Couto G., Ouzounian M., San M., Wang A.B., et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 118 (2008) 879-893
13. Kulkarni A.P., Ghebremariam Y.T., and Kotwal G.J. Curcumin inhibits the classical and the alternate pathways of complement activation. Ann N Y Acad Sci 1056 (2005) 100-112
14. Adapala N., and Chan M.M. Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model. Lab Invest 88 (2008) 1329-1339
15. Babu P.S., and Srinivasan K. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152 (1995) 13-21
16. Babu P.S., and Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166 (1997) 169-175
17. Kurien B.T., and Scofield R.H. Inhibition of p300 and nuclear factor-κB by curcumin and its role in diabetic nephropathy. Nutrition 25 (2009) 973-974
18. Chiu J., Khan Z.A., Farhangkhoee H., and Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25 (2009) 964-972
19. Kurien B.T., Singh A., Matsumoto H., and Scofield R.H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 5 (2007) 567-576
20. Kurien B.T., and Scofield R.H. Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification. Mol Nutr Food Res 53 (2009) 308
21. Kurien B.T., and Scofield R.H. Heat-solubilized curcumin should be considered in clinical trials for increasing bioavailability. Clin Cancer Res 15 (2009) 747
22. Nakamuta M., Ohta S., Tada S., et al. Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med 8 (2001) 553-560
23. Ali B.H., and Mousa H.M. Effect of dimethyl sulfoxide on gentamicin-induced nephrotoxicity in rats. Hum Exp Toxicol 20 (2001) 199-203
24. Farhangkhoee H., Khan Z.A., Chen S., and Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) 3 (2006) 27